Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Nanalysis Scientific Corp. V.NSCI

Alternate Symbol(s):  NSCIF

Healthcare Medical Devices
Nanalysis develops and manufactures compact MRI and NMR devices for clinical, laboratory, and industrial markets. These portable devices require no liquid helium or any other cryogens. The company’s devices are used in diagnostics and chemical analysis across a range of industries (medical, pharma, biotech, mining, oil and gas, and more) as well as numerous government and university research... see more

Recent & Breaking News (TSXV:NSCI)

Nanalysis Reports Second Quarter 2022 Results

PR Newswire August 25, 2022

Nanalysis Announces Second Quarter 2022 Conference Call

PR Newswire August 10, 2022

Nanalysis Scientific Corp. Announces Management Transitions

PR Newswire July 21, 2022

Nanalysis Announces Results of AGM and Appointment of New Director

PR Newswire June 23, 2022

Nanalysis Presenting at Upcoming Conferences

PR Newswire June 6, 2022

Nanalysis Reports First Quarter 2022 Results

PR Newswire May 31, 2022

Nanalysis (TSXV:NSCI) signs $160M security contract

Caroline Egan  May 26, 2022

Nanalysis Scientific Corp. Announces $160 Million Multi Year Contract Win

PR Newswire May 26, 2022

Nanalysis Announces First Quarter 2022 Conference Call and Virtual Annual General Meeting

PR Newswire May 24, 2022

Nanalysis Reports Fourth Quarter and Full Year 2021 Results

PR Newswire April 28, 2022

Nanalysis Announces Fourth Quarter and Full Year 2021 Conference Call

PR Newswire April 20, 2022

Nanalysis Scientific Corp. to Present at NobleCon18

PR Newswire April 13, 2022

/C O R R E C T I O N from Source -- Nanalysis Scientific Corp./

Canada NewsWire April 13, 2022

Nanalysis Scientific Corp. Announces $4,985,000 Funding Contribution from the Canadian Government

PR Newswire March 17, 2022

Nanalysis Scientific Corp. Announces Closing of Initial Equity Investment in Quad Systems

PR Newswire March 8, 2022

Nanalysis Scientific Corp. Announces Grant of Stock Options

PR Newswire March 3, 2022

Nanalysis Recognized as a Top 5 Ranked Company by the TSX Venture 50 for 2021

PR Newswire February 24, 2022

Nanalysis Provides Corporate Update

PR Newswire February 17, 2022

Nanalysis Scientific Corp. Closes Upsized Public Offering and Non-Brokered Private Placement For Gross Proceeds of $15,224,700

PR Newswire February 11, 2022

Nanalysis Announces Corporate Update Conference Call

PR Newswire February 10, 2022